RIGEL PHARMACEUTICALS INC (RIGL) Operating margin 2016–2025
RIGEL PHARMACEUTICALS INC (RIGL) operating margin by fiscal year — reported operating income divided by reported revenue.
42.6%FY2025 · since FY2016: -342.2% → 42.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 42.6% | +29.1 pp |
| FY2024 | 13.5% | +31.0 pp |
| FY2023 | -17.5% | +28.7 pp |
| FY2022 | -46.2% | -37.8 pp |
| FY2021 | -8.4% | +18.3 pp |
| FY2020 | -26.7% | +89.9 pp |
| FY2019 | -116.5% | +46.8 pp |
| FY2018 | -163.3% | +1612.3 pp |
| FY2017 | -1775.6% | -1433.4 pp |
| FY2016 | -342.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice